Propofol infusion for induction and maintenance of anaesthesia in patients with end-stage renal disease. 1998

B Ickx, and I D Cockshott, and L Barvais, and G Byttebier, and L De Pauw, and A Vandesteene, and A A D'Hollander
Department of Anaesthesiology, CUB Erasme, Bruxelles, Belgium.

We have investigated the pharmacokinetics and pharmacodynamics of propofol in 11 patients with end-stage renal disease (ESRD) compared with nine healthy patients during and after a manually controlled three-stage infusion of propofol 21, 12 and 6 mg kg-1 h-1 lasting a minimum of 2 h. Mean total body clearance was not reduced significantly in the ESRD group (30.66 (SD 8.47) ml kg-1 min-1) compared with the control group (33.75 (7.8) ml kg-1 min-1). ESRD patients exhibited a greater, but not statistically significant, volume of distribution at steady state compared with patients in the control group (11.25 (8.86) vs 5.79 (2.14) litre kg-1, respectively). Elimination half-life values were unchanged by renal failure. Mean times to induction of anaesthesia were similar in both groups: 177 (SD 57) and 167 (58) s for the ESRD and control groups, respectively. Waking time after cessation of propofol infusion was significantly shorter in the ESRD group (474 (156) s) compared with the control group (714 (240) s) (P < 0.05). Mean plasma concentrations on waking were similar. We conclude that the pharmacokinetic and pharmacodynamic profiles of propofol after infusion were not markedly affected by renal failure.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003243 Consciousness Sense of awareness of self and of the environment. Consciousnesses
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000762 Anesthesia Recovery Period The period of emergence from general anesthesia, where different elements of consciousness return at different rates. Recovery Period, Anesthesia,Anesthesia Recovery Periods,Period, Anesthesia Recovery,Periods, Anesthesia Recovery,Recovery Periods, Anesthesia

Related Publications

B Ickx, and I D Cockshott, and L Barvais, and G Byttebier, and L De Pauw, and A Vandesteene, and A A D'Hollander
March 1988, Anaesthesia,
B Ickx, and I D Cockshott, and L Barvais, and G Byttebier, and L De Pauw, and A Vandesteene, and A A D'Hollander
May 1990, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
B Ickx, and I D Cockshott, and L Barvais, and G Byttebier, and L De Pauw, and A Vandesteene, and A A D'Hollander
November 1969, Journal of the Iowa Medical Society,
B Ickx, and I D Cockshott, and L Barvais, and G Byttebier, and L De Pauw, and A Vandesteene, and A A D'Hollander
January 1985, Postgraduate medical journal,
B Ickx, and I D Cockshott, and L Barvais, and G Byttebier, and L De Pauw, and A Vandesteene, and A A D'Hollander
November 1984, British journal of anaesthesia,
B Ickx, and I D Cockshott, and L Barvais, and G Byttebier, and L De Pauw, and A Vandesteene, and A A D'Hollander
May 1994, British journal of anaesthesia,
B Ickx, and I D Cockshott, and L Barvais, and G Byttebier, and L De Pauw, and A Vandesteene, and A A D'Hollander
January 1989, British journal of anaesthesia,
B Ickx, and I D Cockshott, and L Barvais, and G Byttebier, and L De Pauw, and A Vandesteene, and A A D'Hollander
May 1990, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
B Ickx, and I D Cockshott, and L Barvais, and G Byttebier, and L De Pauw, and A Vandesteene, and A A D'Hollander
April 1987, Anaesthesia,
B Ickx, and I D Cockshott, and L Barvais, and G Byttebier, and L De Pauw, and A Vandesteene, and A A D'Hollander
September 1991, Minerva anestesiologica,
Copied contents to your clipboard!